
    
      Subjects will come to the clinic on 7 occasions: Screening, Baseline, Day 7, Day 14, Day 21,
      Day 35 (End of Treatment) and Day 42 (Follow-up). The primary efficacy variable will be EASI
      (Eczema Area and Severity Index). The secondary efficacy variables will be EASI, IGA
      (Investigators Global Assessment), SCORAD (SCORing Atopic Dermatitis), Target Lesion Score,
      VAS (Visual Analogue Scale), Skin Tolerability, DLQI (Dermatology Life Quality Index),
      Erythema, TEWL (Transepidermal Water Loss) and Time to Rescue Medication.
    
  